Ann Intern Med. 2014 Aug 5;161(3):189-99. doi: 10.7326/M14-0125.
Data on the association between subclinical thyroid dysfunction and fractures conflict.
To assess the risk for hip and nonspine fractures associated with subclinical thyroid dysfunction among prospective cohorts.
Search of MEDLINE and EMBASE (1946 to 16 March 2014) and reference lists of retrieved articles without language restriction.
Two physicians screened and identified prospective cohorts that measured thyroid function and followed participants to assess fracture outcomes.
One reviewer extracted data using a standardized protocol, and another verified data. Both reviewers independently assessed methodological quality of the studies.
The 7 population-based cohorts of heterogeneous quality included 50,245 participants with 1966 hip and 3281 nonspine fractures. In random-effects models that included the 5 higher-quality studies, the pooled adjusted hazard ratios (HRs) of participants with subclinical hyperthyroidism versus euthyrodism were 1.38 (95% CI, 0.92 to 2.07) for hip fractures and 1.20 (CI, 0.83 to 1.72) for nonspine fractures without statistical heterogeneity (P = 0.82 and 0.52, respectively; I2= 0%). Pooled estimates for the 7 cohorts were 1.26 (CI, 0.96 to 1.65) for hip fractures and 1.16 (CI, 0.95 to 1.42) for nonspine fractures. When thyroxine recipients were excluded, the HRs for participants with subclinical hyperthyroidism were 2.16 (CI, 0.87 to 5.37) for hip fractures and 1.43 (CI, 0.73 to 2.78) for nonspine fractures. For participants with subclinical hypothyroidism, HRs from higher-quality studies were 1.12 (CI, 0.83 to 1.51) for hip fractures and 1.04 (CI, 0.76 to 1.42) for nonspine fractures (P for heterogeneity = 0.69 and 0.88, respectively; I2 = 0%).
Selective reporting cannot be excluded. Adjustment for potential common confounders varied and was not adequately done across all studies.
Subclinical hyperthyroidism might be associated with an increased risk for hip and nonspine fractures, but additional large, high-quality studies are needed.
Swiss National Science Foundation.
亚临床甲状腺功能障碍与骨折之间的关联的数据存在冲突。
评估前瞻性队列中亚临床甲状腺功能障碍与髋部和非脊柱骨折风险的相关性。
对 MEDLINE 和 EMBASE(1946 年至 2014 年 3 月 16 日)进行检索,并对检索到的文章的参考文献列表进行无语言限制的检索。
两名医生筛选并确定了前瞻性队列,这些队列测量了甲状腺功能,并随访参与者以评估骨折结局。
一名审查员使用标准化方案提取数据,另一名审查员验证数据。两名审查员均独立评估了研究的方法学质量。
纳入了 7 项混杂质量的人群队列研究,共有 50245 名参与者,发生了 1966 例髋部骨折和 3281 例非脊柱骨折。在包含 5 项高质量研究的随机效应模型中,亚临床甲状腺功能亢进症患者与甲状腺功能正常患者相比,髋部骨折的校正后危险比(HR)为 1.38(95%CI,0.92 至 2.07),非脊柱骨折的校正后 HR 为 1.20(CI,0.83 至 1.72),无统计学异质性(P=0.82 和 0.52;I2=0%)。7 项队列的汇总估计值分别为髋部骨折 1.26(CI,0.96 至 1.65)和非脊柱骨折 1.16(CI,0.95 至 1.42)。当排除甲状腺素治疗者后,亚临床甲状腺功能亢进症患者的髋部骨折 HR 为 2.16(CI,0.87 至 5.37),非脊柱骨折 HR 为 1.43(CI,0.73 至 2.78)。对于亚临床甲状腺功能减退症患者,高质量研究的 HR 为髋部骨折 1.12(CI,0.83 至 1.51),非脊柱骨折 1.04(CI,0.76 至 1.42)(P 异质性=0.69 和 0.88;I2=0%)。
可能存在选择性报告偏倚。潜在混杂因素的调整在所有研究中各不相同,且调整不充分。
亚临床甲状腺功能亢进症可能与髋部和非脊柱骨折的风险增加相关,但还需要开展更多大型、高质量的研究。
瑞士国家科学基金会。